−0.025AUD
−5.06 MAUD
About BCAL DIAGNOSTICS LIMITED
Sector
Industry
CEO
Shane Ryan
Website
Headquarters
Sydney
Founded
2010
ISIN
AU0000160921
FIGI
BBG011N6JC91
BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. It also associated lipids, biomarker blood test that is used for prevention, screening and monitoring. The company was founded by Jayne Shaw and Ron Philips in 2010 and is headquartered in Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BDX is 0.105 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BCAL DIAGNOSTICS LIMITED stocks are traded under the ticker BDX.
BCAL DIAGNOSTICS LIMITED is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track BCAL DIAGNOSTICS LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, BDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BCAL DIAGNOSTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.